PNC Financial Services Group’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40 | Hold |
31
| – | – | ﹤0.01% | 4870 |
|
|
2025
Q1 | $31 | Hold |
31
| – | – | ﹤0.01% | 4858 |
|
|
2024
Q4 | $28 | Hold |
31
| – | – | ﹤0.01% | 4748 |
|
|
2024
Q3 | $47 | Hold |
31
| – | – | ﹤0.01% | 4748 |
|
|
2024
Q2 | $22 | Hold |
31
| – | – | ﹤0.01% | 4739 |
|
|
2024
Q1 | $29 | Sell |
31
-5
| -14% | -$5 | ﹤0.01% | 4671 |
|
|
2023
Q4 | $40 | Buy |
+36
| New | +$40 | ﹤0.01% | 4579 |
|
|
2018
Q4 | – | Sell |
-30,500
| Closed | -$393K | – | 4060 |
|
|
2018
Q3 | $393K | Buy |
30,500
+10,000
| +49% | +$129K | ﹤0.01% | 1806 |
|
|
2018
Q2 | $234K | Buy |
20,500
+1,000
| +5% | +$11.4K | ﹤0.01% | 2105 |
|
|
2018
Q1 | $137K | Buy |
19,500
+4,500
| +30% | +$31.6K | ﹤0.01% | 2386 |
|
|
2017
Q4 | $98K | Sell |
15,000
-5,000
| -25% | -$32.7K | ﹤0.01% | 2579 |
|
|
2017
Q3 | $124K | Sell |
20,000
-18,000
| -47% | -$112K | ﹤0.01% | 2406 |
|
|
2017
Q2 | $163K | Buy |
38,000
+22,500
| +145% | +$96.5K | ﹤0.01% | 2253 |
|
|
2017
Q1 | $70K | Buy |
15,500
+5,500
| +55% | +$24.8K | ﹤0.01% | 2720 |
|
|
2016
Q4 | $55K | Hold |
10,000
| – | – | ﹤0.01% | 2786 |
|
|
2016
Q3 | $64K | Sell |
10,000
-200
| -2% | -$1.28K | ﹤0.01% | 2698 |
|
|
2016
Q2 | $46K | Buy |
10,200
+2,500
| +32% | +$11.3K | ﹤0.01% | 2871 |
|
|
2016
Q1 | $30K | Buy |
7,700
+3,000
| +64% | +$11.7K | ﹤0.01% | 3063 |
|
|
2015
Q4 | $26K | Buy |
4,700
+4,500
| +2,250% | +$24.9K | ﹤0.01% | 3163 |
|
|
2015
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 4448 |
|
|
2015
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 4542 |
|
|
2015
Q1 | $3K | Buy |
200
+100
| +100% | +$1.5K | ﹤0.01% | 4164 |
|
|
2014
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 3979 |
|